Aminoglycoside ototoxicity following middle ear injection.
D000617:Aminoglycosides / Q000008:administration & dosage / Q000009:adverse effects*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004096:Dihydrostreptomycin Sulfate / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D007758:Ear, Inner / Q000187:drug effects* / Q000648:ultrastructure; D004432:Ear, Middle; D005260:Female; D006168:Guinea Pigs; D006198:Hair Cells, Auditory / Q000187:drug effects / Q000648:ultrastructure; D007267:Injections; D008297:Male; D009355:Neomycin / Q000009:adverse effects; D013307:Streptomycin / Q000009:adverse effects
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D009355:Neomycin; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin